Inspire Medical Systems, Inc. to Present at the Truist Securities Medtech Conference
Inspire Medical Systems (NYSE: INSP) will present at the Truist Securities Medtech Conference on June 18, 2024, at 10:40 a.m. ET. The company specializes in minimally invasive solutions for obstructive sleep apnea. The presentation will be accessible via a live webcast, with a replay available for two weeks on Inspire's investor website.
- Inspire Medical Systems to present at a high-profile Medtech Conference on June 18, 2024, increasing visibility and potential investor interest.
- The presentation will be accessible live, offering real-time engagement with potential investors and stakeholders.
- Replay availability for two weeks ensures extended access to the presentation, potentially reaching a broader audience.
- No new product launches or financial data updates were mentioned, which might be perceived as a lack of immediate growth initiatives.
- The reliance on a webcast could limit engagement compared to in-person interactions.
MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Truist Securities Medtech Conference on Tuesday, June 18, 2024.
Inspire is scheduled to present at 10:40 a.m. Eastern Time. The presentation will be accessible via a live webcast here.
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
When will Inspire Medical Systems present at the Truist Securities Medtech Conference?
How can I access the Inspire Medical Systems presentation at the Truist Securities Medtech Conference?
What is Inspire Medical Systems' stock symbol?
What does Inspire Medical Systems specialize in?
